ESC Professional Premium Access

Worse long term prognosis in new onset HFpEF treated in HF clinics compared to HFrEF and HFmrEF patients; reflecting need for effective treatment in HFpEF. Results from the Stockholm PREFERS Study.

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Congress Presentation

About the speaker

Doctor Mattias Ekstrom

Danderyd University Hospital, Stockholm (Sweden)
0 follower

6 more presentations in this session

Outcomes in patients admitted with diabetic ketoacidosis and heart failure with preserved ejection fraction

Speaker: Unknown H. Alagbo (Coimbra, PT)


Heart failure with mildly reduced ejection fraction is not all alike: the importance of disease trajectory

Speaker: Doctor J. Ferreira (Setubal, PT)


Characterization and prognostic impact of ischemic etiology in heart failure with reduced left ventricular ejection fraction.

Speaker: Mr J. Perea Armijo (Cordoba, ES)


Inter-atrial block and atrial fibrillation predict cardiac adverse events in heart failure with preserved ejection fraction

Speaker: Ms H. Lopez Martinez (Badalona, ES)


Epicardial adipose tissue is associated with an increased risk of mortality and hospitalizations in patients with heart failure with preserved ejection fraction

Speaker: Doctor M. Grubler (Wiener Neustadt, AT)


Access the full session

Heart failure outcomes: effects of phenotypes and comorbidities

Speakers: Doctor M. Ekstrom, Unknown H. Alagbo, Doctor J. Ferreira, Mr J. Perea Armijo, Ms H. Lopez Martinez...

About the event


ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by